Boston Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Boston Scientific Corp
BSX Stock  USD 98.90  1.74  1.79%   
Boston Scientific financial statements provide useful quarterly and yearly information to potential Boston Scientific Corp investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Boston Scientific financial statements helps investors assess Boston Scientific's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Boston Scientific's valuation are summarized below:
Gross Profit
11.5 B
Profit Margin
0.1107
Market Capitalization
143.4 B
Enterprise Value Revenue
9.2028
Revenue
16.7 B
We have found one hundred twenty available fundamental signals for Boston Scientific Corp, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Boston Scientific Corp prevailing market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road. Market Cap is likely to rise to about 124.2 B in 2025. Enterprise Value is likely to rise to about 64.2 B in 2025

Boston Scientific Total Revenue

17.58 Billion

Check Boston Scientific financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Boston Scientific's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 B, Interest Expense of 198.1 M or Selling General Administrative of 6.3 B, as well as many indicators such as Price To Sales Ratio of 4.7, Dividend Yield of 4.0E-4 or PTB Ratio of 5.9. Boston financial statements analysis is a perfect complement when working with Boston Scientific Valuation or Volatility modules.
  
Check out the analysis of Boston Scientific Correlation against competitors.

Boston Scientific Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets41.4 B39.4 B24.4 B
Slightly volatile
Short and Long Term Debt Total11.3 B10.7 B6.9 B
Slightly volatile
Other Current Liabilities3.5 B3.4 B2.2 B
Slightly volatile
Total Current Liabilities6.7 B6.4 B3.7 B
Slightly volatile
Total Stockholder Equity22.9 B21.8 B11.7 B
Slightly volatile
Property Plant And Equipment Net3.5 B3.3 B2.1 B
Slightly volatile
Net Debt10.8 B10.3 B6.4 B
Slightly volatile
Accounts Payable1 B960 M506.6 M
Slightly volatile
Cash582.1 M414 M549.9 M
Slightly volatile
Non Current Assets Total34.1 B32.5 B19.9 B
Slightly volatile
Non Currrent Assets Other1.8 B1.8 B687.7 M
Slightly volatile
Cash And Short Term Investments594 M414 M550.6 M
Slightly volatile
Net Receivables2.7 B2.6 B1.6 B
Slightly volatile
Common Stock Shares Outstanding1.2 B1.5 B1.3 B
Slightly volatile
Liabilities And Stockholders Equity41.4 B39.4 B24.4 B
Slightly volatile
Non Current Liabilities Total6.4 B11 B8.6 B
Slightly volatile
Inventory3 B2.8 B1.4 B
Slightly volatile
Other Current Assets1.2 B1.1 B758.2 M
Slightly volatile
Other Stockholder Equity10.3 B18.8 B15 B
Slightly volatile
Total Liabilities8.9 B17.4 B12 B
Slightly volatile
Property Plant And Equipment Gross7.6 B7.3 B2.8 B
Slightly volatile
Total Current Assets7.3 B6.9 B4.5 B
Slightly volatile
Short Term Debt1.9 B1.8 B651.5 M
Slightly volatile
Intangible Assets5 B6.7 B5.8 B
Slightly volatile
Common Stock Total Equity14.1 M19.6 M15.5 M
Slightly volatile
Common Stock14.6 M19.6 M15.7 M
Slightly volatile
Other Liabilities1.9 B2.1 B2.2 B
Very volatile
Long Term Debt5.7 B8.8 B6 B
Slightly volatile
Good Will9 B17.1 B8.9 B
Slightly volatile
Property Plant Equipment1.7 B3.3 B1.9 B
Slightly volatile
Current Deferred Revenue333.1 M239.4 M292.8 M
Slightly volatile
Long Term Debt Total6.6 B10.3 B6.4 B
Slightly volatile
Capital Surpluse19.3 B23.3 B18.2 B
Slightly volatile
Non Current Liabilities Other602.3 M634 M2 B
Slightly volatile
Long Term Investments473.9 M555 M326.1 M
Slightly volatile
Short and Long Term Debt1.9 B1.8 B751.4 M
Slightly volatile
Cash And Equivalents838.2 M1.1 B584 M
Slightly volatile
Capital Lease Obligations325.3 M527 M168.6 M
Slightly volatile
Net Invested Capital26.1 B32.4 B19 B
Slightly volatile
Capital Stock18.4 M19.6 M16.6 M
Slightly volatile

Boston Scientific Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization1.4 B1.4 B737.6 M
Slightly volatile
Selling General Administrative6.3 B6 B3.6 B
Slightly volatile
Total Revenue17.6 B16.7 B9.9 B
Slightly volatile
Gross Profit12.1 B11.5 B6.8 B
Slightly volatile
Other Operating Expenses14.9 B14.1 B8.4 B
Slightly volatile
EBIT2.7 B2.6 B1.4 B
Slightly volatile
EBITDA1.6 B2.6 B1.9 B
Slightly volatile
Cost Of Revenue5.5 B5.3 B3.1 B
Slightly volatile
Total Operating Expenses9.3 B8.9 B5.3 B
Slightly volatile
Research Development915.7 M1.6 B1 B
Slightly volatile
Selling And Marketing Expenses180.8 M203.4 M221.8 M
Slightly volatile
Non Recurring321.5 M338.4 M906.9 M
Slightly volatile
Interest Income181.8 M107 M211.2 M
Pretty Stable
Reconciled Depreciation1.1 B1.3 B928.2 M
Slightly volatile

Boston Scientific Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow668.6 M1.1 B735.2 M
Slightly volatile
Depreciation1.3 B1.3 B893.7 M
Slightly volatile
Capital Expenditures829.5 M790 M420.1 M
Slightly volatile
Total Cash From Operating Activities3.6 B3.4 B1.5 B
Slightly volatile
End Period Cash Flow673.6 M606 M742.2 M
Slightly volatile
Stock Based Compensation224.8 M266 M152.2 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio4.77.84824.3202
Slightly volatile
Dividend Yield4.0E-44.0E-40.0011
Slightly volatile
PTB Ratio5.96.03744.6972
Pretty Stable
Days Sales Outstanding67.3955.751560.8454
Slightly volatile
Book Value Per Share15.714.95288.2937
Slightly volatile
Operating Cash Flow Per Share2.452.33441.0695
Slightly volatile
Stock Based Compensation To Revenue0.01730.01590.0154
Slightly volatile
Capex To Depreciation0.590.62250.5529
Pretty Stable
PB Ratio5.96.03744.6972
Pretty Stable
EV To Sales5.28.46524.9209
Slightly volatile
Inventory Turnover2.791.87082.3852
Slightly volatile
Days Of Inventory On Hand169195159
Slightly volatile
Payables Turnover10.535.4767.875
Slightly volatile
Sales General And Administrative To Revenue0.290.330.3576
Slightly volatile
Research And Ddevelopement To Revenue0.130.09640.1089
Pretty Stable
Capex To Revenue0.08390.04720.0425
Slightly volatile
Cash Per Share0.380.28130.3884
Slightly volatile
POCF Ratio47.9438.263338.3652
Pretty Stable
Capex To Operating Cash Flow0.220.230.3229
Very volatile
Days Payables Outstanding38.8566.65452.8313
Slightly volatile
EV To Operating Cash Flow52.4541.271143.735
Pretty Stable
Intangibles To Total Assets0.410.60350.5951
Very volatile
Current Ratio1.91.08141.4993
Slightly volatile
Receivables Turnover4.826.54695.9896
Pretty Stable
Graham Number21.520.473811.0021
Slightly volatile
Shareholders Equity Per Share15.5314.79448.2625
Slightly volatile
Debt To Equity0.470.49360.6109
Very volatile
Capex Per Share0.560.53690.2966
Slightly volatile
Revenue Per Share11.9511.38097.0187
Slightly volatile
Interest Debt Per Share7.897.515.1128
Slightly volatile
Debt To Assets0.210.27280.2725
Slightly volatile
Short Term Coverage Ratios1.841.931976.5409
Slightly volatile
Operating Cycle236251219
Slightly volatile
Price Book Value Ratio5.96.03744.6972
Pretty Stable
Days Of Payables Outstanding38.8566.65452.8313
Slightly volatile
Price To Operating Cash Flows Ratio47.9438.263338.3652
Pretty Stable
Company Equity Multiplier1.661.80962.18
Slightly volatile
Long Term Debt To Capitalization0.220.29180.3427
Pretty Stable
Total Debt To Capitalization0.270.33050.3694
Very volatile
Debt Equity Ratio0.470.49360.6109
Very volatile
Quick Ratio0.610.64230.9855
Slightly volatile
Dividend Paid And Capex Coverage Ratio2.774.34813.4964
Slightly volatile
Net Income Per E B T0.750.8121.3241
Very volatile
Cash Ratio0.06150.06470.1646
Very volatile
Cash Conversion Cycle183184166
Very volatile
Operating Cash Flow Sales Ratio0.170.20510.1434
Pretty Stable
Days Of Inventory Outstanding169195159
Slightly volatile
Days Of Sales Outstanding67.3955.751560.8454
Slightly volatile
Cash Flow Coverage Ratios0.50.31970.2891
Slightly volatile
Price To Book Ratio5.96.03744.6972
Pretty Stable
Fixed Asset Turnover5.315.08414.9163
Slightly volatile
Capital Expenditure Coverage Ratio2.864.34813.5579
Slightly volatile
Price Cash Flow Ratio47.9438.263338.3652
Pretty Stable
Debt Ratio0.210.27280.2725
Slightly volatile
Cash Flow To Debt Ratio0.50.31970.2891
Slightly volatile
Price Sales Ratio4.77.84824.3202
Slightly volatile
Asset Turnover0.670.42510.5045
Slightly volatile
Gross Profit Margin0.770.68610.6881
Slightly volatile
Price Fair Value5.96.03744.6972
Pretty Stable

Boston Scientific Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap124.2 B118.3 B52.5 B
Slightly volatile
Enterprise Value64.2 B61.2 B47.8 B
Slightly volatile

Boston Fundamental Market Drivers

Forward Price Earnings34.1297
Cash And Short Term Investments414 M

Boston Upcoming Events

31st of January 2024
Upcoming Quarterly Report
View
24th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
31st of January 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Boston Scientific Financial Statements

Boston Scientific investors use historical fundamental indicators, such as Boston Scientific's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Boston Scientific. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue239.4 M333.1 M
Total Revenue16.7 B17.6 B
Cost Of Revenue5.3 B5.5 B
Stock Based Compensation To Revenue 0.02  0.02 
Sales General And Administrative To Revenue 0.33  0.29 
Research And Ddevelopement To Revenue 0.10  0.13 
Capex To Revenue 0.05  0.08 
Revenue Per Share 11.38  11.95 
Ebit Per Revenue 0.16  0.10 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
CRMSalesforce
CRMSalesforce

Additional Tools for Boston Stock Analysis

When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY